” Brixmor Property Group Inc(NYSE:BRX) has delivered to investors a clean and simple way to play the U.S. grocery-anchored strips,” says Deutsche’s Vin Chao, starting the Blackstone (BX) spinoff with a Buy at $23 price target (Blackstone owns a 73% stake).”With portfolio and balance sheet repositioning addressed pre-IPO, BRX can focus its efforts on driving above-average earnings growth via occupancy gains, improving rents, and select redevelopment opportunities.”Chao also likes the relative valuation, and expects a total return of 20% over the next year – a combination of 10% earnings growth driving the shares to $23, and a 4% dividend yield.

Insys Therapeutics Inc(NASDAQ:INSY) -18.4% premarket following news it received a subpoena from the Department of Health and Human Services in connection with an investigation of potential violations involving HHS programs.The subpoena requests documents regarding Subsys, including INSY’s sales and marketing practices related to the product; Subsys, a sublingual spray to treat pain in opioid-tolerate cancer patients, is one of its INSY’s two marketed products.